Balanced news tone
News Sentiment
4587 sentiment intelligence
PeptiDream Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
48
Balanced news tone
8 relevant articles
News tone and price action are not far from neutral.
71/100 classification confidence.
directly relevant articles
high-authority source matches
-0.9% over one week, +9.3% over four weeks, trend inactive, and below fair value.
Price to sales forward of Peptidream Inc. – TSE:4587
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
71/100 classification
One-week reaction
-0.9%
Price digesting
Trend fit
Trend inactive
9.3% over four weeks
Fair value
-42.9%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
7
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TradingView
Direct company coverage
Price to sales forward of Peptidream Inc. – TSE:4587
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 23:12
- Source
- TradingView
Market source
Direct company coverage
How The Story Is Shifting For PeptiDream (TSE:4587) After The Price Target Reset
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 23 Apr 2026 07:00
- Source
- Market source
Business Wire
Direct company coverage
PeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration Partner
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Business Wire
simplywall.st
Direct company coverage
Analysts Have Lowered Expectations For PeptiDream Inc. (TSE:4587) After Its Latest Results
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 18 Feb 2026 08:00
- Source
- simplywall.st
BioSpace
Direct company coverage
National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Mar 2025 07:00
- Source
- BioSpace
BioWorld News
Direct company coverage
Novartis, Peptidream expand peptide discovery effort in $2.7B deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 07 May 2024 07:00
- Source
- BioWorld News
Business Wire
Direct company coverage
PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Dec 2022 08:00
- Source
- Business Wire
Reuters
Direct company coverage
Biotech-for-hire PeptiDream charts new path and becomes short target
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 13 Nov 2019 08:00
- Source
- Reuters